Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
Iván Martínez‐Baz, Ana Miqueleiz, Itziar Casado, et al.
Eurosurveillance (2021) Vol. 26, Iss. 21
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Xuemei He, Weiqi Hong, Xiangyu Pan, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 838-845
Open Access | Times Cited: 494
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 315
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 230
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
PLoS Medicine (2022) Vol. 19, Iss. 5, pp. e1003991-e1003991
Open Access | Times Cited: 93
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 82
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales
Steven Kerr, Stuart Bedston, Geneviève Cézard, et al.
The Lancet (2024) Vol. 403, Iss. 10426, pp. 554-566
Open Access | Times Cited: 29
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
Brechje de Gier, Stijn P. Andeweg, Rosa Joosten, et al.
Eurosurveillance (2021) Vol. 26, Iss. 31
Open Access | Times Cited: 77
Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
Clara Mazagatos, Susana Monge, Carmen Olmedo, et al.
Eurosurveillance (2021) Vol. 26, Iss. 24
Open Access | Times Cited: 74
Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Eurosurveillance (2021) Vol. 26, Iss. 39
Open Access | Times Cited: 69
Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
Ramy Mohamed Ghazy, Rasha Ashmawy, Noha Alaa Hamdy, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 350-350
Open Access | Times Cited: 58
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Zikria Saleem, Brian Godman, Aislinn Cook, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 56
Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study
Maylis Layan, Mayan Gilboa, Tal Gonen, et al.
American Journal of Epidemiology (2022) Vol. 191, Iss. 7, pp. 1224-1234
Open Access | Times Cited: 51
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
Esther Kissling, Mariëtte Hooiveld, Virginia Martin, et al.
Eurosurveillance (2021) Vol. 26, Iss. 29
Open Access | Times Cited: 51
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants
Dídac Florensa, Jordi Nofre, Radu Spaimoc, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
Yot Teerawattananon, Thunyarat Anothaisintawee, Chatkamol Pheerapanyawaranun, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261930-e0261930
Open Access | Times Cited: 29
Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
Xuemei He, Cai He, Weiqi Hong, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 932-971
Open Access | Times Cited: 17
Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study
Iván Martínez‐Baz, Ana Miqueleiz, Nerea Egüés, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 3, pp. 410-417
Open Access | Times Cited: 16
Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature
Pablo Coto‐Segura, María Fernández-Prada, Marc Mir‐Bonafé, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 1, pp. 141-143
Open Access | Times Cited: 34
Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
Jesús Castilla, Óscar Lecea, Carmen Martín Salas, et al.
Eurosurveillance (2022) Vol. 27, Iss. 33
Open Access | Times Cited: 26
Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study
Haruhisa Fukuda, Megumi Maeda, Fumiko Murata
Vaccine (2023) Vol. 41, Iss. 23, pp. 3556-3563
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top